Epigenetic targeting of myeloid-derived suppressor cells: time to move into infectious diseases?
Main Author: | Morten Frier Gjerstorff |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1247715/full |
Similar Items
-
Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance
by: Morten Frier Gjerstorff, et al.
Published: (2023-06-01) -
Novel Insights Into Epigenetic Reprogramming and Destabilization of Pericentromeric Heterochromatin in Cancer
by: Morten Frier Gjerstorff, et al.
Published: (2020-11-01) -
Myeloid-derived suppressor cells in Chronic myeloid leukemia
by: Cesarina eGiallongo, et al.
Published: (2015-05-01) -
The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
by: Ruiyang Ren, et al.
Published: (2023-08-01) -
Interaction between Polycomb and SSX Proteins in Pericentromeric Heterochromatin Function and Its Implication in Cancer
by: Simone Johansen, et al.
Published: (2020-01-01)